Table 2_A pharmacovigilance study of Bruton’s tyrosine kinase inhibitors: a multidimensional analysis based on FAERS and VigiBase.xlsx
Introduction<p>The safety concerns of Bruton's tyrosine kinase inhibitors (BTKis) have garnered significant attention due to their severe adverse reactions. However, no existing studies have utilized VigiBase, the world's largest adverse event reporting system, to conduct post-market...
Saved in:
| Hovedforfatter: | Han Qu (4391905) (author) |
|---|---|
| Andre forfattere: | Yuqi Jia (12074459) (author), Zizhen Liu (10067249) (author), Zuan Li (13285615) (author), Xin Zhao (71840) (author), Zhenghua Wu (548294) (author), Guorong Fan (2294386) (author), Yuefen Lou (11843792) (author) |
| Udgivet: |
2025
|
| Fag: | |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|
Lignende værker
-
Table 1_A pharmacovigilance study of Bruton’s tyrosine kinase inhibitors: a multidimensional analysis based on FAERS and VigiBase.docx
af: Han Qu (4391905)
Udgivet: (2025) -
Table 3_Disproportionality analysis of biliary adverse events associated with fibrates using the JADER and FAERS databases.xlsx
af: Satoko Watanabe (59124)
Udgivet: (2025) -
Table 2_Disproportionality analysis of biliary adverse events associated with fibrates using the JADER and FAERS databases.xlsx
af: Satoko Watanabe (59124)
Udgivet: (2025) -
Table 4_Disproportionality analysis of biliary adverse events associated with fibrates using the JADER and FAERS databases.xlsx
af: Satoko Watanabe (59124)
Udgivet: (2025) -
Table 1_Disproportionality analysis of biliary adverse events associated with fibrates using the JADER and FAERS databases.xlsx
af: Satoko Watanabe (59124)
Udgivet: (2025)